Search results
Results From The WOW.Com Content Network
mRNA medicine contains no animal products or preservatives, making medicine accessible for as many people as possible. Our platform enables rapid design, research and testing of multiple mRNAs, within days. Our novel production methods allow us to get medicines to more people, faster.
We’re making biotech history. Messenger RNA is not new technology, but we are discovering new ways to use it to treat and prevent illnesses and diseases. Since our founding in 2010, we have worked to build the industry's leading mRNA technology platform.
Learn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2024-2025 Formula and how it helps protect against emerging variants, following ACIP recommendation.
Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.
The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
We are committed to creating an inclusive and diverse environment for our team members across the globe. Moderna employees drive our achievements in bringing innovative medicines to patients. We have pledged to achieve net-zero carbon emissions by 2030 in Scopes 1 & 2 and by 2045 in Scope 3.
Clinical trial data from research assay confirmed Moderna's updated COVID-19 vaccine showed an 8.7 to 11-fold increase in neutralizing antibodies against circulating variants, including BA.2.86, EG.5, and FL.1.5.1 variants
Bring your passion and find a diverse and inclusive environment where everyone is welcome and empowered to do their best work. Employee Resource Groups are voluntary, employee-led groups that harness the power of belonging and allyship to serve our people, our company and the community at large.
Overview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.
I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on guidance from the U.S. FDA.